Year |
Citation |
Score |
2016 |
Chen Q, Chen L, Chen G, Pu Y, Xing C. Wound-edge protection devices in gastrointestinal surgery: a meta-analysis Journal of Surgical Research. 206: 472-480. DOI: 10.1016/j.jss.2016.08.034 |
0.408 |
|
2015 |
Lin WC, Kuo KL, Shi CS, Wu JT, Hsieh JT, Chang HC, Liao SM, Chou CT, Chiang CK, Chiu WS, Chiu TY, Pu YS, Ho IL, Wang ZH, Chang SC, et al. MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study. American Journal of Cancer Research. 5: 3350-62. PMID 26807316 |
0.482 |
|
2015 |
Ho IL, Kuo KL, Liu SH, Chang HC, Hsieh JT, Wu JT, Chiang CK, Lin WC, Tsai YC, Chou CT, Hsu CH, Pu YS, Shi CS, Huang KH. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. Scientific Reports. 5: 16948. PMID 26592553 DOI: 10.1038/srep16948 |
0.484 |
|
2015 |
Kuo KL, Ho IL, Shi CS, Wu JT, Lin WC, Tsai YC, Chang HC, Chou CT, Hsu CH, Hsieh JT, Chang SC, Pu YS, Huang KH. MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies. Cancer Letters. 363: 127-36. PMID 25615422 DOI: 10.1016/j.canlet.2015.01.015 |
0.486 |
|
2014 |
Chen CH, Hsieh JT, Huang KH, Pu YS, Chang HC. Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving Leuplin depot as androgen deprivation therapy. Plos One. 9: e105091. PMID 25121948 DOI: 10.1371/journal.pone.0105091 |
0.389 |
|
2013 |
Chiang BJ, Pu YS, Chung SD, Liu SP, Yu HJ, Wang SM, Chang HC, Chiang IN, Huang CY. Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience. Thescientificworldjournal. 2013: 452107. PMID 24453852 DOI: 10.1155/2013/452107 |
0.38 |
|
2013 |
Huang KH, Kuo KL, Ho IL, Chang HC, Chuang YT, Lin WC, Lee PY, Chang SC, Chiang CK, Pu YS, Chou CT, Hsu CH, Liu SH. Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells. Plos One. 8: e82034. PMID 24349176 DOI: 10.1371/journal.pone.0082034 |
0.471 |
|
2013 |
Kuo KL, Lin WC, Ho IL, Chang HC, Lee PY, Chung YT, Hsieh JT, Pu YS, Shi CS, Huang KH. 2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. Plos One. 8: e68703. PMID 23967052 DOI: 10.1371/journal.pone.0068703 |
0.474 |
|
1999 |
Sung JF, Lin RS, Pu YS, Chen YC, Chang HC, Lai MK. Risk factors for prostate carcinoma in Taiwan: a case-control study in a Chinese population. Cancer. 86: 484-91. PMID 10430257 DOI: 10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P |
0.394 |
|
Show low-probability matches. |